Although several studies have applied radiomics to identify EGFR mutations in either BMs or primary lung cancers using brain MRI, the study populations were relatively small, especially for patients with EGFR mutations, or the EGFR mutation status of the BMs was determined based on the primary tumor status, rather than samples obtained from the BMs (14–23). Here, EGFR is linked to neoplasm.